| Authors: |
Boyce RW; Department of Comparative Biology and Safety Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA. Electronic address: rboyce@amgen.com., Varela A; Charles River Preclinical Services-Montreal, 22022 Transcanadienne, Senneville, QC H9X 3R3, Canada. Electronic address: aurore.varela@crl.com., Chouinard L; Charles River Preclinical Services-Montreal, 22022 Transcanadienne, Senneville, QC H9X 3R3, Canada. Electronic address: luc.chouinard@crl.com., Bussiere JL; Department of Comparative Biology and Safety Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA. Electronic address: bussierj@amgen.com., Chellman GJ; Charles River Preclinical Services-Nevada, 6995 Longley Lane, Reno, NV 89511, USA. Electronic address: gary.chellman@crl.com., Ominsky MS; Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA. Electronic address: mominsky@amgen.com., Pyrah IT; Department of Comparative Biology and Safety Sciences, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA. Electronic address: ipyrah@amgen.com. |